Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Obesity01:24

Obesity

1.5K
The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in...
1.5K
Drug Dosing: Obese Patients01:21

Drug Dosing: Obese Patients

332
In the United States, obesity is a prominent concern. It is linked to heightened mortality rates due to increased occurrences of conditions such as hypertension, atherosclerosis, coronary artery disease, and diabetes compared to nonobese individuals. A patient is classified as obese if their actual body weight surpasses the ideal or desirable body weight by 20%, based on Metropolitan Life Insurance Company data. Ideal body weights consider average weights and heights for males and females...
332
Pharmacokinetics in Obese Patients: Drug Absorption and Distribution01:25

Pharmacokinetics in Obese Patients: Drug Absorption and Distribution

358
Obesity significantly alters the pharmacokinetic processes of drug absorption and distribution, presenting unique challenges in medical treatment. The increased fat tissue and decreased lean muscle in obese individuals can significantly affect how drugs are absorbed into the body and distributed across different tissues. This alteration can lead to variances in the effectiveness and safety of medications, necessitating adjustments in dosing or drug selection for obese patients.One notable...
358
Stress Prevention and Stress Management Techniques VI01:30

Stress Prevention and Stress Management Techniques VI

306
Adopting a healthier lifestyle often requires overcoming significant challenges, but leveraging psychological, social, and cultural resources can facilitate meaningful change. Effective self-change hinges on understanding and applying key tools such as motivation and goal setting, which help sustain efforts toward long-term health benefits.
Motivation and Self-Determination
Motivation, the driving force behind behavior, plays a pivotal role at every stage of the change process. The research...
306
Models of Health Promotion and Illness Prevention I01:25

Models of Health Promotion and Illness Prevention I

3.0K
A model is a theoretical way to understand a concept or an idea. Models can overcome barriers to health regardless of diverse economic and cultural backgrounds. In addition, models make the task easier by providing different ways to approach complex issues. There are two major health promotion models: the health belief model and the health promotion model.
The health belief model (HBM) attempts to predict health-related behavior in specific belief patterns. According to the HBM, a person's...
3.0K
Models of Health Promotion and Illness Prevention II01:18

Models of Health Promotion and Illness Prevention II

2.2K
The person's health status fluctuates continually, varying from being in good health to becoming ill and returning to being healthy. To understand the concept of illness prevention, there are two models. First, the health-illness continuum model is a graphic representation of an individual's wellness. It states that a person is considered healthy in the absence of physical disease and the presence of good emotional health.
The agent-host-environment model states that disease results...
2.2K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Variation in the Commissioning of Semaglutide for the Treatment of Obesity and Overweight Across England: Results of Three Freedom of Information-Based Mapping Exercises Across the 42 Integrated Care Boards of England.

Clinical obesity·2025
Same author

The Impact of Bariatric Surgery on Coronary Microvascular Function Assessed Using Automated Quantitative Perfusion CMR.

JACC. Cardiovascular imaging·2024
Same author

Efficacy and safety of once-weekly semaglutide 2·4 mg versus placebo in people with obesity and prediabetes (STEP 10): a randomised, double-blind, placebo-controlled, multicentre phase 3 trial.

The lancet. Diabetes & endocrinology·2024
Same author

Pharmacotherapy for older people with obesity.

European journal of internal medicine·2024
Same author

Real-world data of a digitally enabled, time-restricted eating weight management program in public sector workers living with overweight and obesity in the United Kingdom: A service evaluation of the Roczen program.

Obesity science & practice·2024
Same author

Impact of BMI and comorbidities on efficacy of once-weekly semaglutide: Post hoc analyses of the STEP 1 randomized trial.

Obesity (Silver Spring, Md.)·2023

Related Experiment Video

Updated: Mar 20, 2026

Multidisciplinary Approach to Obesity Management: A Case Report
05:10

Multidisciplinary Approach to Obesity Management: A Case Report

Published on: May 30, 2025

1.4K

A Practical Guide to Engaging Individuals with Obesity.

Barbara M McGowan1

  • 1Department of Diabetes and Endocrinology, Guy's and St Thomas' NHS Foundation Trust, London, UK.

Obesity Facts
|June 5, 2016
PubMed
Summary

Obesity is a chronic disease requiring public health attention. This article examines European barriers and strategies for general practitioners to effectively manage obesity in patients.

Area of Science:

  • Public Health
  • General Practice
  • Chronic Disease Management

Background:

  • Obesity is a recognized chronic disease and a major public health concern globally.
  • In Europe, a significant portion of the adult population is overweight or obese, impacting health and healthcare systems.
  • General practitioners (GPs) are pivotal in addressing the obesity epidemic but face numerous engagement challenges.

Purpose of the Study:

  • To identify obstacles faced by patients in accessing healthcare services for obesity management.
  • To explore effective approaches for engaging individuals with obesity within primary care settings.
  • To facilitate the management of obesity as a chronic condition from a European perspective.

Main Methods:

  • Review of European perspectives on healthcare access for obesity.

More Related Videos

A Method for Manipulating Blood Glucose and Measuring Resulting Changes in Cognitive Accessibility of Target Stimuli
08:01

A Method for Manipulating Blood Glucose and Measuring Resulting Changes in Cognitive Accessibility of Target Stimuli

Published on: August 12, 2016

9.6K
An Acupoint Catgut-embedding Therapy for Treating Obesity
04:50

An Acupoint Catgut-embedding Therapy for Treating Obesity

Published on: April 4, 2025

1.8K

Related Experiment Videos

Last Updated: Mar 20, 2026

Multidisciplinary Approach to Obesity Management: A Case Report
05:10

Multidisciplinary Approach to Obesity Management: A Case Report

Published on: May 30, 2025

1.4K
A Method for Manipulating Blood Glucose and Measuring Resulting Changes in Cognitive Accessibility of Target Stimuli
08:01

A Method for Manipulating Blood Glucose and Measuring Resulting Changes in Cognitive Accessibility of Target Stimuli

Published on: August 12, 2016

9.6K
An Acupoint Catgut-embedding Therapy for Treating Obesity
04:50

An Acupoint Catgut-embedding Therapy for Treating Obesity

Published on: April 4, 2025

1.8K
  • Discussion of barriers encountered by general practitioners (GPs) and healthcare professionals (HCPs).
  • Analysis of strategies to improve GP-patient engagement in obesity management.

    • Main Results:

    • Key barriers include time constraints, lack of evidence, patient sensitivities, service availability, inadequate HCP training, and limited effective therapies.
    • Patients face significant obstacles in accessing appropriate healthcare services for obesity.
    • Effective engagement requires addressing systemic and individual-level challenges.

    Conclusions:

    • Addressing obesity as a chronic disease necessitates improved support systems and training for GPs.
    • Overcoming barriers to care is crucial for successful patient engagement and obesity management.
    • A multi-faceted approach is needed to facilitate chronic disease management of obesity in Europe.